Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:181:269-374.
doi: 10.1007/112_2020_17.

Membrane Transporters and Channels in Melanoma

Ines Böhme  1 , Roland Schönherr  2 , Jürgen Eberle  3 , Anja Katrin Bosserhoff  4   5
Affiliations
Review

Membrane Transporters and Channels in Melanoma

Ines Böhme et al. Rev Physiol Biochem Pharmacol. 2021.

Abstract

Recent research has revealed that ion channels and transporters can be important players in tumor development, progression, and therapy resistance in melanoma. For example, members of the ABC family were shown to support cancer stemness-like features in melanoma cells, while several members of the TRP channel family were reported to act as tumor suppressors.Also, many transporter proteins support tumor cell viability and thus suppress apoptosis induction by anticancer therapy. Due to the high number of ion channels and transporters and the resulting high complexity of the field, progress in understanding is often focused on single molecules and is in total rather slow. In this review, we aim at giving an overview about a broad subset of ion transporters, also illustrating some aspects of the field, which have not been addressed in detail in melanoma. In context with the other chapters in this special issue on "Transportome Malfunctions in the Cancer Spectrum," a comparison between melanoma and these tumors will be possible.

Keywords: Apoptosis; Cell proliferation; Channels; Melanocyte; Melanoma; Metastasis; Mutation; Nevus; Prognosis; Transporters; Tumor development; Tumor progression.

PubMed Disclaimer

References

    1. Abele R, Tampe R (2004) The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 19:216–224. https://doi.org/10.1152/physiol.00002.2004 - DOI
    1. Adachi H, Suzuki T, Abe M, Asano N, Mizutamari H, Tanemoto M, Nishio T, Onogawa T, Toyohara T, Kasai S, Satoh F, Suzuki M, Tokui T, Unno M, Shimosegawa T, Matsuno S, Ito S, Abe T (2003) Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol 285:F1188–F1197. https://doi.org/10.1152/ajprenal.00402.2002 - DOI - PubMed
    1. Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, Bianchi G, Kroemer G, Pistoia V, Di Virgilio F (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72:2957–2969. https://doi.org/10.1158/0008-5472.CAN-11-1947 - DOI - PubMed - PMC
    1. Adinolfi E, Capece M, Franceschini A, Falzoni S, Giuliani AL, Rotondo A, Sarti AC, Bonora M, Syberg S, Corigliano D, Pinton P, Jorgensen NR, Abelli L, Emionite L, Raffaghello L, Pistoia V, Di Virgilio F (2015) Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res 75:635–644. https://doi.org/10.1158/0008-5472.CAN-14-1259 - DOI - PubMed - PMC
    1. Alexander SPH, Mathie A, Peters JA (2011) Transporters. Br J Pharmacol 164:S213–S278. https://doi.org/10.1111/j.1476-5381.2011.01649_8.x - DOI

LinkOut - more resources